News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Opinion: Get to Know Why People Openly Share Genomic Data
Tobias Haeusermann | May 9, 2017
It’s not only about health but also about exploring ancestry and contributing to science.
RNA-Seq Reveals Previously Hidden, Genetic Disorder–Causing Mutations
Anna Azvolinsky | Apr 19, 2017
Adding RNA sequencing analysis to genomic sequencing helps scientists uncover mutations likely responsible for genetic disorders they might otherwise miss.
FDA OKs Marketing of DTC Genetic Health-Risk Tests
Diana Kwon | Apr 7, 2017
23andMe customers can now receive information about genetic risk for diseases including Parkinson’s and celiac.
Genetic Nondiscrimination in Canada
Joshua A. Krisch | Mar 9, 2017
Canada’s parliament is set for a final vote on a proposed genetic nondiscrimination act.
Genotyping “Surrogates” Misdiagnoses Deadly Heart Condition
Kerry Grens | Nov 2, 2016
Family members with a certain gene variant had unnecessary interventions, highlighting the potential hazards of precision medicine.
The End of Sex
Tanya Lewis | May 13, 2016
Legal expert Henry Greely envisions a world in which advances in biotechnology obviate the need for sexual reproduction as we know it.
Study: Genetic Tests Don’t Change Behavior
Jef Akst | Mar 17, 2016
Knowing one’s genetic risk for particular diseases doesn’t encourage behavior modifications, according to a study.
Genome Sequencing Standards
Kerry Grens | May 18, 2015
The US National Institute of Standards and Technology develops a reference sample to check the validity of genetic sequences.
Study Participants Want to Know
Jef Akst | Apr 29, 2015
Most people who participate in research that involves genetic testing prefer to be told if they have mutations that increase their risk of treatable disease, according to a large survey.
Jenny Rood | Apr 21, 2015
Color Genomics announces a new, lower-cost BRCA mutation test, while Inserm and Quest Diagnostics reveal plans to pool patient data to investigate rare mutations.